NCT03562741
Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile
Recruiting
NAAges 16+InterventionalTreatmentKrunal PatelInvestigator-initiated
~500 participants
Updated 2026-02-20 on ClinicalTrials.gov
What's tested:Fecal Microbiota Transplantation
At a glance
Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Clostridium Difficile (C. diff) resolution'
Measured over 12 months
Conditions
Where it's being run
1 sites across 1 statesMassachusetts1
Study leadership
- Krunal Patel · PRINCIPAL_INVESTIGATOR · UMass Medical School
Who to contact
Anne Foley
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Two or more recurrences of C. difficile infection (CDI) with recurrence defined as a positive test result, e.g. Polymerase Chain Reaction (PCR) test and with appropriate symptoms within 2-8 weeks of last positive result, provided that symptoms from earlier episode resolved with or without therapy.
Failed standard therapy with oral metronidazole and/or oral vancomycin
One or more episodes of severe CDI resulting in hospitalization and not responding to standard antibiotic therapy. Hospitalization for CDI occurs in the setting of severe diarrhea, abdominal pain and signs of systemic toxicity
Exclusion
Age \<16 years old
patients with acute severe colonic dilation at risk for colonic perforation
What this trial measures
- Clostridium Difficile (C. diff) resolution'12 months
Longterm resolution of C. diff associated diarrhea after Fecal Microbiota Transplantation (FMT) therapy